4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-15-004224
CIK 0001316175operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:28 PM ET
Size
5.4 KB
Accession
0001214659-15-004224
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2015-05-21+28,846→ 28,846 totalExercise: $4.75Exp: 2025-05-21→ Common Stock (28,846 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of May 21, 2015. This stock option is fully exercisable on May 21, 2016.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:28 PM ET
- Size
- 5.4 KB